drugset / Trial / NCT04459676
Study to Assess Efficacy and Safety Relative to Standard of Care in Patients With COVID-19 Pneumonia
Phase 2
Unknown
100 enrolled
Angion Biomedica Corp
CTI Clinical Trial and Consulting Services · collab
RandomizedParallel-groupQuadruple-blindTreatment
Summary
To assess the clinical efficacy of ANG-3777 relative to the standard of care in reducing the severity and progression of pulmonary and renal dysfunction and mortality in adult patients hospitalized with COVID-19 pneumonia
Timeline
- Start
- 2020-07-31
- Primary completion
- 2021-04-30
- Completion
- 2021-04-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | TEREVALEFIM | Small molecule | — | Intravenous |